Clinical trial

Fish Oil for the Treatment of Depression in Patients With Multiple Sclerosis

NCT00122954 · Oregon Health and Science University, Other · Completed

Key facts

NCT number NCT00122954
Title Fish Oil for the Treatment of Depression in Patients With Multiple Sclerosis
Official title Fish Oil as an Adjunct Therapy for Depression in Multiple Sclerosis
Lead sponsor Oregon Health and Science University, Other
Collaborators National Center for Complementary and Integrative Health (NCCIH) NIH
Status Completed
Phase Phase 1/Phase 2
Study type Interventional
Conditions Multiple Sclerosis, Depression
Intervention type Drug
Interventions Fish oil concentrate, Placebo
Enrollment 39
Start date Jul 1, 2005
Primary completion Jun 1, 2009
Completion Jun 1, 2009
First posted Jul 22, 2005
Last update posted Jun 8, 2017
Countries United States

At a glance

  • 1–9 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies